Correlation analysis of survivin, ING4, CXCL8 and VEGF expression in prostate cancer tissue

Lingwei Kong; Rushan Qi; Guangchun Zhou; Sentai Ding

Correlation analysis of survivin, ING4, CXCL8 and VEGF expression in prostate cancer tissue

Am J Transl Res. 2021 Dec 15;13(12):13784-13790. eCollection 2021.

Authors

Lingwei Kong¹, Rushan Qi², Guangchun Zhou¹, Sentai Ding^{3

4}

Affiliations

¹ Department of Urology, Chengwu People's Hospital Chengwu County, Heze 274200, Shandong Province, China.
² Department of Urology, The First People's Hospital of Taian Taian, Shandong Province, China.
³ Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250021, Shandong Province, China.
⁴ Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University Jinan 250021, Shandong Province, China.

PMID: 35035717
PMCID: PMC8748150

Abstract

Objective: This study aimed to investigate the expression of Survivin, inhibitor of growth 4 (ING4), CXC chemokine ligand 8 (CXCL8), vascular endothelial growth factor (VEGF), and the correlation between Survivin, ING4, CXCL8 and VEGF in prostate cancer (PCa) tissues.

Methods: From January 2019 to December 2019, 51 patients from Chengwu People's Hospital and The First People's Hospital of Taian, with PCa were selected as the PCa group and 47 patients with benign prostatic hyperplasia (BPH) were included as the BPH group. The expression of Survivin, ING4, CXCL8 and VEGF in both groups and among patients with different clinical stages in the PCa group were compared, and the correlation between Survivin, ING4, CXCL8 and VEGF expression in PCa tissues was analyzed.

Results: Survivin, ING4, CXCL8, and VEGF expression differed significantly between the two groups (P<0.05). The Survivin positive expression rate, CXCL8 positive expression rate, and VEGF positive expression rate in the PCa group were significantly higher than those in the BPH group (P<0.05), and ING4 positive expression rate in the PCa group was significantly lower than that in the BPH group (P<0.05). Survivin positive expression rate, CXCL8 positive expression rate, and VEGF positive expression rate were significantly higher in PCa patients with stage III+IV than those of stage I+II (P<0.05), and ING4 positive expression rate in PCa patients in stage III+IV was significantly lower than that in stage I+II (P<0.05). Kendall's tau-b analysis, VEGF was positively correlated with Survivin and CXCL8 (P<0.05) and negatively correlated with ING4 (P<0.05) in PCa tissues.

Conclusion: Survivin, CXCL8, and VEGF were highly expressed and ING4 was lowly expressed in PCa tissues, which was correlated with clinical stage; additionally, Survivin, ING4, CXCL8, and VEGF played a synergistic role with each other in the development and progression of PCa.

Keywords: CXC chemokine ligand 8; Prostate cancer; growth inhibitory factor; survivin; vascular endothelial growth factor.